メニューにジャンプコンテンツにジャンプ

トップページ > 診療科・部門 > 診療科(内科系) > 放射線核医学科 > 研究実績・活動実績 > 2016年度発表論文等一覧

2016年度発表論文等一覧

原著論文-英文

  1. Minamimoto R, Jamali M, Gevaert O, Echegaray S, Khuong A, Hoang CD, Shrager JB, Plevritis SK, Rubin DL, Leung AN, Napel S, Quon A.
    Prediction of EGFR and KRAS Mutation in non-small cell lung cancer using advanced quantitative 18F FDG-PET/CT metrics.
    Oncotarget. 2017 in press.
  2. Hotta M, Minamimoto R, Suzuki D, Takahashi A.
    Multicentric Reticulohistiocytosis Mimicking Malignancy on 18F-FDG PET/CT.
    Clin Nucl Med. 2017 (in press).
  3. Minamimoto R, Iagaru A, Jamali M, Holley D, Barkhodari A, Vasanawala S, Zaharchuk G.
    Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRI.
    PLoS One. 12(1):e0167262, 2017.
  4. Minamimoto R, Barkhodari A, Harshman L, Srinivas S, Quon A.
    Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma.
    PLoS One. 11(4):e0153321, 2016.
  5. Minamimoto R, Fayad L, Advani R, Vose J, Macapinlac H, Meza J, Hankins J, Mottaghy F, Juweid M, Quon A.
    Prospective multicenter comparison of early interim 18F-FLT PET/CT versus 18F-FDG PET/CT using IHP, EORTC, Deauville, and PERCIST criteria for early therapeutic monitoring of diffuse large B-cell lymphoma.
    Radiology. 280(1):220-229, 2016.
  6. Minamimoto R, Karam A, Jamali M, Barkhodari A, Gambhir SS, Dorigo O, Iagaru A.
    Pilot Prospective Evaluation of 18F FPPRGD2 PET/CT in Patients with Cervical and Ovarian Cancers.
    Eur J Nucl Med Mol Imaging. 43(6):1047-1055, 2016.
  7. Minamimoto R, Hancock S, Schneider B, Chin F, Jamali M, Loening AM, Vasanawala S, Gambhir SS, Iagaru A.
    Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 57(4):557-562, 2016.
  8. Nakaigawa N, Kondo K, Ueno D, Namura K, Makiyama K, Kobayashi K, Shioi K, Ikeda I, Kishida T, Kaneta T, Minamimoto R, Tateishi U, Inoue T, Yao M.
    The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.
    BMC Cancer. 7(1):39, 2017.
  9. Nakaigawa N, Kondo K, Tateishi U, Minamimoto R, Kaneta T, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Kubota Y, Inoue T, Yao M.
    FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.
    BMC Cancer. 16:67, 2016.
  10. Kitajima K, Yamamoto S, Fukushima K, Minamimoto R, Kamai T, Jadvar H.
    Update on advances in molecular PET in urological oncology.
    Jpn J Radiol. 34(7):470-485, 2016.
  11. Kondo A, Ishii H, Aoki S, Suzuki M, Nagasawa H, Kubota K, Minamimoto R, Arakawa A, Tominaga M, Arai H.
    Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.
    Ann Nucl Med. 30(9):608-618, 2016.
  12. Thompson HM, Minamimoto R, Jamali M, Barkhodari A, von Eyben R, Iagaru A.
    A Prospective, Matched Comparison Study of SUV Measurements From Time-of-Flight Versus Non-Time-of-Flight PET/CT Scanners.
    Clin Nucl Med. 41(7):e323-326, 2016.
  13. Awano N, Inomata M, Ikushima S, Yamada D, Hotta M, Tsukuda S, Kumasaka T, Takemura T, Eishi Y.
    Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonaryfibrosis and emphysema: comparison with idiopathic pulmonary fibrosis and emphysema alone.
    Histopathology. 2017 (in press)
  14. Meshitsuka S, Shingaki S, Hotta M, Goto M, Wada Y, Kobayashi M, Ukawa Y, Segesaka Y, Nojima M, Suzuki K.
    Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis.
    Int J Hematol. 105(3): 295-308, 2017.

原著論文-和文

口頭・ポスター発表-国際学会・研究会

  1. Minamimoto R, Hotta M, Toyohara J, Okasaki M, Morooka M, Miyata Y, Kameyama M, Nakajima K, Miwa A, Kubota K.
    Prospective Comparison of 11C-4DST, 18F-FDG PET/CT and Whole-body MRI in the Patients with Multiple Myeloma.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  2. Minamimoto R, Hotta M, Toyohara J, Morooka M, Nakajima K, Kubota K.
    Pilot Comparison of 4DST and FDG PET/CT for Early Therapy Monitoring of Advanced Non Small Cell Lung Cancer.
    RSNA. Chicago, 2016.
  3. Iagaru A, Minamimoto R, Loening A, Mueller A, Berndt M, Stephens A, Vasanawala S.
    Biochemically recurrent prostate cancer: 68Ga-RM2 (formerly known as 68Ga-Bombesin or BAY86-7548) PET/MRI is superior to conventional imaging.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  4. Sonni I, Minamimoto R, Jamali, M, Hatami N, Berndt M, Koglin N, Stephens A, Iagaru A, Chin F, Gambhir S, Mittra E.
    Imaging of tumor-associated system xC- activity with 18F-fluoropropylglutamate (18F-FSPG) PET/CT for intracranial malignancies.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  5. Wu F, Baratto L, Minamimoto R, Advani R, Sabile J, Mittra E.
    Prognostic value of LUGANO, EORTC, PERCIST and IHP criteria in patients with diffuse large B cell lymphoma based on 18F-FDG PET/CT.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  6. Sonni I, Minamimoto R, Loening A, Taviani V, Jamali M, Hatami N, Baratto L, Wu F, Gambhir S, Vasanawala S, Iagaru A.
    Imaging Patients with Breast and Prostate Cancers Using Combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  7. Baratto L, Wu F, Minamimoto R, Sabile J, Advani R, Mittra E.
    Prognostic role of baseline 18F-FDG PET/CT in DLBCL patients.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  8. Baratto L, Wu F, Minamimoto R, Sabile J, Advani R, Mittra E.
    The role of interim 18F-FDG PET/CT in DLBCL patients: SUV max, SUV mean and SUV peak as predictive metabolic parameters of prognosis.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  9. Iagaru A, Sonni I, Minamimoto R, Loening A, Vasanawala S.
    Ga68 RM2 PET/MRI Evaluation of Gastrin-Releasing Peptide Receptor Status in Patients with Biochemically Recurrent Prostate Cancer and Negative Conventional Imaging.
    EANM. 2016.
  10. Sonni I, Minamimoto R, Tavian V, Loening A, Gambhir, S. Vasanawala S, Iagaru A.
    Imaging patients with breast and prostate cancers using combined 18F-NaF/18F-FDG and TOF simultaneous PET/MRI.
    EANM. 2016.
  11. Sonni I, Minamimoto R, Jamali M, Mittra E.
    Imaging of tumor-associated system xc- activity with 18Ffluoropropylglutamate (FSPG) PET/CT for intracranial malignancies.
    EANM. 2016.
  12. Hotta M, Minamimoto R, Morooka M, Kameyama M, Kubota K, Toyohara J.
    Pilot comparison of 4DST and FDG PET/CT for early therapy monitoring of advanced non small cell lung cancer.
    RSNA 2016 102th Radiological Society of North America. Illinoi, Chicago, USA, Nov, 2016.
  13. Hotta M, Minamimoto R, Toyohara J, Okazaki M, Morooka M, Kameyama M, Miwa A, Kubota K.
    Prospective comparison of 11C-4DST, 18-FDG PET/CT and whole-body MRI in the patients with multiple myeloma.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  14. Hotta M, Morooka M, Ishii K, Ito K, Sakata M, Kameyama M, Minamimoto R, Kubota K.
    Fingerprints of mild HIV-associated neurocognitive disorders (HAND): FDG and VBM study.
    SNMMI annual meeting. San Diego, CA, USA, Jun, 2016.
  15. Hotta M, Yamada T, Shimizu T, Watanabe T, Harada A, Sato H, Yamashita A, Yokote H, Tsukuda S, Ohgi K.
    CT imaging features of congenital heart disease in children: What every radiologist should know.
    ARRS 2016 American Roentgen Ray Society Annual Meeting. Los Angeles, CA, USA, Apr, 2016.

口頭・ポスター発表-国内学会・研究会

  1. 堀田 昌利, 南本 亮吾, 豊原 潤, 諸岡 都, 亀山 征史, 中島 和彦, 野原 京子, 山田 和彦, 窪田 和雄.
    11C-4DSTと18F-FDGにおける食道癌の描出能に関する比較検討.
    第56回日本核医学会学術総会. 名古屋, 11月, 2016.
  2. 堀田 昌利, 南本 亮吾, 諸岡 都, 亀山 征史, 中島 和彦, 砂岡 史生, 児玉 清幸, 梶原 宏則, 窪田 和雄.
    ソマトスタチン受容体シンチグラフィ(111In-ペントテレオクチド)の生理的集積に関する検討.
    第56回日本核医学会学術総会. 名古屋, 11月, 2016.

著書・総説

総説-英文

  1. Mansi R, Minamimoto R, Mäcke H, Iagaru AH.
    Bombesin-Targeted PET of Prostate Cancer. 
    Nucl Med. 57(Suppl 3):67S-72S, Oct, 2016.

単行本-和文

  1. 南本 亮吾, 窪田 和雄.
    肺癌 - ガイドラインに基づいた治療戦略と実地診療への活用: FDG PET/CTの上手な利用法.
    Medical Practice. 33(2), 文光堂, 東京, p205-207, 2016.
  2. 堀田 昌利, 南本 亮吾.
    多発性骨髄腫における画像検査.
    血液内科. 74(2), 科学評論社、東京, p138-143, 2017.
  3. 南本 亮吾.
    海外留学・研究報告 スタンフォード大学留学記.
    臨床核医学. 11, p91-92, 2016.

その他